Dr.AlignNavi
InnoDtech, Inc. · Decision date Oct 7, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for Dr.AlignNavi, a 510(k) submitted by InnoDtech, Inc. of Gwangju, KR, under number K262378. The device falls under the classification name Orthodontic Software, regulation 872.5470, with primary product code PNN and subsequent product code LLZ. The application was received 07/13/2026 and decided 10/07/2026; the review panel and medical specialty are both Dental, and the submission is listed as Traditional, not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan.
SESE denotes clearance of this 510(k), not premarket approval of a new device system. The record does not describe the specific software functions, components, or any changed item, and no summary statement is present in the supplied data, so the basis for substantial equivalence and any clinical performance information remain unknown. CTNS Corp. is listed as correspondent, with Hyeon gu Lee as applicant contact and Eunsol Jung as correspondent contact.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Dental
- Decision date
- Oct 7, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262378
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- InnoDtech, Inc.
- Product code
- PNN
- Decision code
- SESE
- Decision date
- Oct 7, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Orthodontic Software.
- Applicant
- InnoDtech, Inc.
- Product code
- PNN
- FDA device class
- 2
FDA decision timeline
K262378 received
Application receipt date recorded by FDA.
K262378 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code PNN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LuxDesignK260421 | LuxCreo, Inc. | 510(k) clearance | Oct 23, 2026 | FDA |
Invisalign SystemK262196 | Align Technology, Inc. | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
InnoDtech, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Gwangju
Sources and methodology
- Original FDA record: K262378
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
